SUCCESS STORIES NEWS EVENTS
Lilly is a leading innovation-driven pharmaceutical corporation, with a growing portfolio of best-in-class, first-in-class pharmaceutical products achieved through the application of the latest research from its own worldwide laboratories. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis, erectile dysfunction, and many other conditions. Headquartered in Indianapolis, USA, Lilly provides answers—through medicines and information—for some of the world's most urgent medical needs. As its products save and improve lives, they also save overall health care costs: they are often less expensive than other forms of health care, such as surgery and hospitalization.

With a strong heritage spanning over 130 years, we employ more than 41,000 people worldwide, 8,300 of whom work in R&D, and we market our medicines in ...

» » »
7.1.2009
World Bank report praises Turkey's privatization practices

7.1.2009
More privatizations planned as crisis fades

7.1.2009
Turkey to extend lottery sale tender deadline

7.1.2009
Turkey to lure Gulf funds with new bonds

7.1.2009
PSA group to increase purchases from Turkish suppliers

5.1.2009
Privatization plans for 2009 have been announced

5.1.2009
CEO salaries to be kept under supervision

5.1.2009
Telecom investments amid crisis to keep Turkey’s IT sector competitive

5.1.2009
“Turkey retains its attraction for the investors”

5.1.2009
Hero has built its second plant and entrusted the world market to a Turkish executive


10.01.2009 - 11.01.2009

Breaking News »



close pop-up